These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 1824678)

  • 1. Use of polymerase chain reactions to monitor minimal residual disease in acute lymphoblastic leukemia patients.
    Yokota S; Hansen-Hagge TE; Ludwig WD; Reiter A; Raghavachar A; Kleihauer E; Bartram CR
    Blood; 1991 Jan; 77(2):331-9. PubMed ID: 1824678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysis.
    Beishuizen A; Verhoeven MA; van Wering ER; Hählen K; Hooijkaas H; van Dongen JJ
    Blood; 1994 Apr; 83(8):2238-47. PubMed ID: 8161789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of oligonucleotide probes directed against T cell antigen receptor gamma delta variable-(diversity)-joining junctional sequences as a general method for detecting minimal residual disease in acute lymphoblastic leukemias.
    Macintyre EA; d'Auriol L; Duparc N; Leverger G; Galibert F; Sigaux F
    J Clin Invest; 1990 Dec; 86(6):2125-35. PubMed ID: 2174915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The detection of residual acute lymphoblastic leukemia cells with immunologic methods and polymerase chain reaction: a comparative study.
    Campana D; Yokota S; Coustan-Smith E; Hansen-Hagge TE; Janossy G; Bartram CR
    Leukemia; 1990 Sep; 4(9):609-14. PubMed ID: 1975635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal residual disease in childhood acute lymphoblastic leukemia: analysis of patients in continuous complete remission or with consecutive relapse.
    Biondi A; Yokota S; Hansen-Hagge TE; Rossi V; Giudici G; Maglia O; Basso G; Tell C; Masera G; Bartram CR
    Leukemia; 1992 Apr; 6(4):282-8. PubMed ID: 1316978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detectable molecular residual disease at the beginning of maintenance therapy indicates poor outcome in children with T-cell acute lymphoblastic leukemia.
    Dibenedetto SP; Lo Nigro L; Mayer SP; Rovera G; Schilirò G
    Blood; 1997 Aug; 90(3):1226-32. PubMed ID: 9242556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of T-cell receptor delta gene rearrangement in T-cell malignancies by clonal specific polymerase chain reaction and its application to detect minimal residual disease.
    Chan DW; Liang R; Kwong YL; Chan V
    Am J Hematol; 1996 Jul; 52(3):171-7. PubMed ID: 8756082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective monitoring and quantitation of residual blasts in childhood acute lymphoblastic leukemia by polymerase chain reaction study of delta and gamma T-cell receptor genes.
    Cavé H; Guidal C; Rohrlich P; Delfau MH; Broyart A; Lescoeur B; Rahimy C; Fenneteau O; Monplaisir N; d'Auriol L
    Blood; 1994 Apr; 83(7):1892-902. PubMed ID: 8142656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern of T-cell receptor delta gene rearrangement by Southern blotting and polymerase chain reaction technique in Hong Kong Chinese patients with non-T-cell hematological malignancies.
    Chan DW; Liang R; Kwong YL
    Hematol Oncol; 1996 Jun; 14(2):57-66. PubMed ID: 8876635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved detection of minimal residual leukemia through modifications of polymerase chain reaction analyses based on clonospecific T cell receptor junctions.
    Seriu T; Hansen-Hagge TE; Erz DH; Bartram CR
    Leukemia; 1995 Feb; 9(2):316-20. PubMed ID: 7869770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of clonal evolution at Ig/TCR loci in acute lymphoblastic leukaemia by single-strand conformation polymorphism studies and highly resolutive PCR derived methods: implication for a general strategy of minimal residual disease detection.
    Baruchel A; Cayuela JM; MacIntyre E; Berger R; Sigaux F
    Br J Haematol; 1995 May; 90(1):85-93. PubMed ID: 7786801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of minimal residual disease in acute lymphoblastic leukemia by in vitro amplification of rearranged T-cell receptor delta chain sequences.
    Hansen-Hagge TE; Yokota S; Bartram CR
    Blood; 1989 Oct; 74(5):1762-7. PubMed ID: 2676018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal residual disease (MRD) detection using rearrangement of immunoglobulin/T cell receptor genes in adult patients with acute lymphoblastic leukemia (ALL).
    Shahkarami S; Mehrasa R; Younesian S; Yaghmaie M; Chahardouli B; Vaezi M; Rezaei N; Nikbakht M; Alimoghaddam K; Ghavamzadeh A; Tavakkoly-Bazzaz J; Ghaffari SH
    Ann Hematol; 2018 Apr; 97(4):585-595. PubMed ID: 29392424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged persistence of PCR-detectable minimal residual disease after diagnosis or first relapse predicts poor outcome in childhood B-precursor acute lymphoblastic leukemia.
    Steenbergen EJ; Verhagen OJ; van Leeuwen EF; van den Berg H; Behrendt H; Slater RM; von dem Borne AE; van der Schoot CE
    Leukemia; 1995 Oct; 9(10):1726-34. PubMed ID: 7564517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective monitoring of minimal residual disease during the course of chemotherapy in patients with acute lymphoblastic leukemia, and detection of contaminating tumor cells in peripheral blood stem cells for autotransplantation.
    Seriu T; Yokota S; Nakao M; Misawa S; Takaue Y; Koizumi S; Kawai S; Fujimoto T
    Leukemia; 1995 Apr; 9(4):615-23. PubMed ID: 7723394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal residual disease monitoring in adult T-cell acute lymphoblastic leukemia: a molecular based approach using T-cell receptor G and D gene rearrangements.
    Gameiro P; Mortuza FY; Hoffbrand AV; Foroni L
    Haematologica; 2002 Nov; 87(11):1126-34. PubMed ID: 12414341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of minimal residual disease in T-cell acute lymphoblastic leukemia using polymerase chain reaction predicts impending relapse.
    Neale GA; Menarguez J; Kitchingman GR; Fitzgerald TJ; Koehler M; Mirro J; Goorha RM
    Blood; 1991 Aug; 78(3):739-47. PubMed ID: 1859886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell receptor delta gene recombination in common acute lymphoblastic leukemia: preferential usage of V delta 2 and frequent involvement of the J alpha cluster.
    Yokota S; Hansen-Hagge TE; Bartram CR
    Blood; 1991 Jan; 77(1):141-8. PubMed ID: 1898632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent ongoing T-cell receptor rearrangements in childhood B-precursor acute lymphoblastic leukemia: implications for monitoring minimal residual disease.
    Steenbergen EJ; Verhagen OJ; van Leeuwen EF; van den Berg H; von dem Borne AE; van der Schoot CE
    Blood; 1995 Jul; 86(2):692-702. PubMed ID: 7606000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL.
    van der Velden VH; Jacobs DC; Wijkhuijs AJ; Comans-Bitter WM; Willemse MJ; Hählen K; Kamps WA; van Wering ER; van Dongen JJ
    Leukemia; 2002 Aug; 16(8):1432-6. PubMed ID: 12145681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.